Audit of high dose palliative radiotherapy survival outcomes in patients with non-small cell lung cancer (NSCLC) in Leeds between 1999 and 2009

被引：0
|
作者：
Murray, P. F. [1 ]
Illsley, A. L. [1 ]
Bond, M. G. [1 ]
Bottomley, D. M. [1 ]
Franks, K. N. [1 ]
Henry, A. M. [1 ]
Snee, M. P. [1 ]
Turner, R. N. [1 ]
机构：
[1] St James Univ Hosp, Dept Clin Oncol, St Jamess Inst Oncol, Leeds, W Yorkshire, England
来源：
LUNG CANCER | 2011年 / 71卷
关键词：
D O I：
10.1016/S0169-5002(11)70115-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
115
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [1] Survival outcomes of palliative thoracic radiotherapy in non-small cell lung cancer
    Merrick, Christopher
    Tough, Fay
    LUNG CANCER, 2022, 165 : S59 - S59
  • [2] An Institutional Audit of Maximum Heart Dose in Patients Treated With Palliative Radiotherapy for Non-small Cell Lung Cancer
    Nieder, Carsten
    Imingen, Kristian S.
    IN VIVO, 2021, 35 (02): : 955 - 958
  • [3] An audit of sequential chemoradiotherapy for non-small cell lung cancer (NSCLC) at the Leeds Cancer Centre (LCC)
    Sun, F.
    Littlejohns, A.
    Fakih, O.
    Clarke, K.
    Franks, K.
    Snee, M.
    Dickinson, P.
    Jain, P.
    LUNG CANCER, 2019, 127 : S77 - S78
  • [4] An audit of survival in patients diagnosed with non-small cell lung cancer (NSCLC) and brain metastasis
    Mitchell, T.
    Maclaren, V.
    LUNG CANCER, 2018, 115 : S31 - S31
  • [5] High dose palliative radiotherapy for non-small cell lung cancer: Should it be computer planned?
    Borthwick, K.
    Patrick, S.
    Robertshaw, H.
    Stuart, R. D.
    LUNG CANCER, 2010, 67 : S35 - S35
  • [6] Audit: Beneficial resource implications of adopting MRC palliative radiotherapy guidelines for non-small cell lung cancer (NSCLC).
    Lander, F
    Ritchie, D
    BRITISH JOURNAL OF CANCER, 1996, 74 : PO22 - PO22
  • [7] Palliative radiotherapy in patients with metastatic non-small cell lung cancer
    Nieder, Carsten
    Norum, Jan
    ANNALS OF PALLIATIVE MEDICINE, 2013, 2 (01) : 51 - 53
  • [8] Survival of patients (pts) treated with high-dose radiotherapy (RT) and concurrent chemotherapy for unresectable non-small cell lung cancer (NSCLC)
    Schild, S.
    Graham, D.
    Hillman, S.
    Vora, S.
    Yolanda, G.
    Molina, J.
    Shahidi, H.
    Kugler, J.
    Adjei, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Hypofractionated accelerated high-dose radiotherapy (RT) in non-small cell lung cancer (NSCLC)
    Brennan, S. M.
    Fitzpatrick, D.
    Armstrong, J.
    McElroy, A.
    Dunne, M.
    Shea, C. O.
    Thirion, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] A re-audit of patient selection and mortality rates after palliative radiotherapy (PRT) in patients with non-small cell lung cancer (NSCLC).
    Bayman, N.
    Chan, C.
    Faivre-Finn, C.
    CLINICAL ONCOLOGY, 2015, 27 : S4 - S4
12345